154 related articles for article (PubMed ID: 36807106)
1. Venous thromboembolism in children with acute lymphoblastic leukemia in China: a report from the Chinese Children's Cancer Group-ALL-2015.
Yin M; Wang H; Guan X; Gao J; Yang M; Wang N; Liu T; Tang J; Leung AWK; Zhou F; Wu X; Huang J; Li H; Hu S; Tian X; Jiang H; Cai J; Zhai X; Shen S; Hu Q
Front Med; 2023 Jun; 17(3):518-526. PubMed ID: 36807106
[TBL] [Abstract][Full Text] [Related]
2. Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial.
O'Brien SH; Rodriguez V; Lew G; Newburger JW; Schultz CL; Orgel E; Derr K; Ranalli MA; Esbenshade AJ; Hochberg J; Kang HJ; Dinikina Y; Mills D; Donovan M; Dyme JL; Favatella NA; Mitchell LG;
Lancet Haematol; 2024 Jan; 11(1):e27-e37. PubMed ID: 37980924
[TBL] [Abstract][Full Text] [Related]
3. A retrospective study of venous thromboembolism in acute leukemia patients treated at the University of Texas MD Anderson Cancer Center.
Vu K; Luong NV; Hubbard J; Zalpour A; Faderl S; Thomas DA; Yang D; Kantarjian H; Kroll MH
Cancer Med; 2015 Jan; 4(1):27-35. PubMed ID: 25487644
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism following L-asparaginase treatment for lymphoid malignancies in Korea.
Lee JH; Lee J; Yhim HY; Oh D; Bang SM
J Thromb Haemost; 2017 Apr; 15(4):655-661. PubMed ID: 28150907
[TBL] [Abstract][Full Text] [Related]
5. Incidence and Risk Factors of Venous Thromboembolism in Childhood Acute Lymphoblastic Leukaemia - a Population-Based Analysis of the Austrian Berlin-Frankfurt-Münster (BFM) Study Group.
Gidl A; Füreder A; Benesch M; Dworzak M; Engstler G; Jones N; Kropshofer G; Pötschger U; Poyer F; Tamesberger M; Witt V; Mann G; Attarbaschi A;
Pediatr Hematol Oncol; 2023 Mar; 40(2):181-191. PubMed ID: 35848787
[TBL] [Abstract][Full Text] [Related]
6. Assessment of provider practices regarding venous thromboembolism management and prevention in pediatric acute leukemia patients.
Degliuomini M; Cooley V; Mauer E; Gerber LM; Acharya S; Kucine N
J Thromb Thrombolysis; 2021 Jul; 52(1):209-213. PubMed ID: 33486673
[TBL] [Abstract][Full Text] [Related]
7. Venous Thromboembolism After Peripherally Inserted Central Catheters Placement in Children With Acute Leukemia: A Single-center Retrospective Cohort Study.
Ren Y; Chang L; Zhao B; Zhang X; Wan Y; Zhu X; Zhang H
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e407-e409. PubMed ID: 32427704
[TBL] [Abstract][Full Text] [Related]
8. Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL-SEHOP-PETHEMA-2013.
Ruiz-Llobet A; Gassiot S; Sarrate E; Zubicaray J; Dapena JL; Rives S; Sevilla J; Menárguez López Á; Panesso Romero M; Montoya C; Vagace JM; Molina Hurtado JR; García-Morín M; García Abós M; Mendoza Sánchez MC; Lendínez F; Palomo Moraleda P; Tallón M; González B; Urrutia E; Serna JV; Peláez Pleguezuelos I; Martínez Merino M; Ramos Elbal E; Orellana E; Benítez Muñoz H; Berrueco R
J Thromb Haemost; 2022 Jun; 20(6):1390-1399. PubMed ID: 35289066
[TBL] [Abstract][Full Text] [Related]
9. Increasing Incidence and Recurrence Rate of Venous Thromboembolism in Paediatric Oncology Patients in One Single Centre Over 25 Years.
Klaassen ILM; van Els AL; van de Wetering MD; van Ommen CH
Thromb Haemost; 2017 Nov; 117(11):2156-2162. PubMed ID: 28981557
[TBL] [Abstract][Full Text] [Related]
10. Markers of hypercoagulability in children with newly diagnosed acute lymphoblastic leukemia.
Carmona R; Kizilocak H; Marquez-Casas E; Vasquez S; Ji L; Ko RH; Young G; Jaffray J
Pediatr Blood Cancer; 2022 Mar; 69(3):e29522. PubMed ID: 34963026
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemia.
Mateos MK; Trahair TN; Mayoh C; Barbaro PM; Sutton R; Revesz T; Barbaric D; Giles JE; Alvaro F; Mechinaud F; Catchpoole D; Kotecha RS; Dalla-Pozza L; Quinn MCJ; MacGregor S; Chenevix-Trench G; Marshall GM
Thromb Res; 2019 Jun; 178():132-138. PubMed ID: 31030032
[TBL] [Abstract][Full Text] [Related]
12. Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival.
Ku GH; White RH; Chew HK; Harvey DJ; Zhou H; Wun T
Blood; 2009 Apr; 113(17):3911-7. PubMed ID: 19088376
[TBL] [Abstract][Full Text] [Related]
13. Obesity and risk for venous thromboembolism from contemporary therapy for pediatric acute lymphoblastic leukemia.
Prasca S; Carmona R; Ji L; Ko RH; Bhojwani D; Rawlins YA; Mittelman SD; Young G; Orgel E
Thromb Res; 2018 May; 165():44-50. PubMed ID: 29567586
[TBL] [Abstract][Full Text] [Related]
14. L-asparaginase and venous thromboembolism in acute lymphocytic leukemia.
Goyal G; Bhatt VR
Future Oncol; 2015; 11(17):2459-70. PubMed ID: 26274336
[TBL] [Abstract][Full Text] [Related]
15. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
16. The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols.
Grace RF; Dahlberg SE; Neuberg D; Sallan SE; Connors JM; Neufeld EJ; Deangelo DJ; Silverman LB
Br J Haematol; 2011 Feb; 152(4):452-9. PubMed ID: 21210774
[TBL] [Abstract][Full Text] [Related]
17. Screening for coagulopathy and identification of children with acute lymphoblastic leukemia at a higher risk of symptomatic venous thrombosis: an AIEOP experience.
Santoro N; Colombini A; Silvestri D; Grassi M; Giordano P; Parasole R; Barisone E; Caruso R; Conter V; Valsecchi MG; Masera G; Rizzari C
J Pediatr Hematol Oncol; 2013 Jul; 35(5):348-55. PubMed ID: 23619106
[TBL] [Abstract][Full Text] [Related]
18. Treatment of catheter-related thrombosis in patients with hematologic malignancies: A Venous thromboEmbolism Network U.S. retrospective cohort study.
Baumann Kreuziger L; Gaddh M; Onadeko O; George G; Wang TF; Oo TH; Jaglal M; Houghton DE; Streiff MB; Gali R; Feng M; Simpson P; Billett HH
Thromb Res; 2021 Jun; 202():155-161. PubMed ID: 33862470
[TBL] [Abstract][Full Text] [Related]
19. Comparison Between Non-vitamin K Antagonist Oral Anticoagulants and Low-Molecular-Weight Heparin in Asian Individuals With Cancer-Associated Venous Thromboembolism.
Chen DY; Tseng CN; Hsieh MJ; Lan WC; Chuang CK; Pang ST; Chen SW; Chen TH; Chang SH; Hsieh IC; Chu PH; Wen MS; Chen JS; Chang JW; See LC; Huang WK
JAMA Netw Open; 2021 Feb; 4(2):e2036304. PubMed ID: 33533929
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of enoxaparin treatment in venous thromboembolic disease during acute leukemia.
Imberti D; Vallisa D; Anselmi E; Moroni CF; Bertè R; Lazzaro A; Bernuzzi P; Arcari AL; Cavanna L
Tumori; 2004; 90(4):390-3. PubMed ID: 15510981
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
